EAM
ZBH icon

Empirical Asset Management’s Zimmer Biomet ZBH Stock Holding History

Empirical Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,191
Closed -$346K – 365
2024
Q2 		$346K Buy
+3,191
New +$376K 0.13% 220

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Empirical Asset Management's ZBH Position: Q3 2024 in Review

Empirical Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 3,191 shares — an estimated $346K sold.

Empirical Asset Management first reported a position in ZBH in Q2 2024 and held it in 1 quarter. The position peaked at $346K in Q2 2024. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Empirical Asset Management reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Empirical Asset Management sold 3,191 Zimmer Biomet shares in Q3 2024, an estimated $346K.
  • Empirical Asset Management first reported a position in Zimmer Biomet in Q2 2024 and held it in 1 quarter.
  • Empirical Asset Management's Zimmer Biomet position peaked at $346K in Q2 2024.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Empirical Asset Management's 13F filing for Q3 2024, filed 11 Oct 2024.